Clinical significance of miR-155 expression in breast cancer and effects of miR-155 ASO on cell viability and apoptosis

Oncology Reports

Volumn 27, Issue 4, 2012, Pages 1149-1155

  Zheng, Shu Rong ^a   Guo, Gui Long ^a   Zhang, Wei ^a   Huang, Guan Li ^a   Hu, Xiao Qu ^a   Zhu, Jin ^b   Huang, Qi Di ^a   You, Jie ^a   Zhang, Xiao Hua ^a  

^a WENZHOU MEDICAL UNIVERSITY   (China)

^b Jiaxing Maternity and Child Health Care Hospital   (China)

Author keywords

Antisense oligonucleotide; Apoptosis; Breast neoplasms; Clinicopathological features; microRNA 155; microRNAs; Viability

Indexed keywords

MICRORNA; MICRORNA 155; UNCLASSIFIED DRUG;

ADVANCED CANCER; APOPTOSIS; ARTICLE; BREAST CANCER; CANCER CELL; CELL PROLIFERATION; CELL VIABILITY; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN REGULATION; FEMALE; FLOW CYTOMETRY; GENE OVEREXPRESSION; GENE SEQUENCE; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; UPREGULATION;

ANALYSIS OF VARIANCE; APOPTOSIS; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CARCINOMA, LOBULAR; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; CHINA; FEMALE; FLOW CYTOMETRY; HUMANS; LYMPHATIC METASTASIS; MICRORNAS; NEOPLASM STAGING; OLIGONUCLEOTIDES, ANTISENSE; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; TRANSFECTION; TUMOR MARKERS, BIOLOGICAL; UP-REGULATION;

EID: 84863043199     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2012.1634     Document Type: Article

References (42)

1. Ambros V: MicroRNA pathways in flies and worms: growth, death, fat, stress, and timing. Cell 113: 673-676, 2003.
2. Bartel DP: MicroRNAs: target recognition and regulatory functions. Cell 136: 215-233, 2009.
3. Griffiths-Jones S, Grocock RJ, van Dongen S, Bateman A and Enright AJ: miRBase: microRNA sequences, targets and gene nomenclature. Nucleic Acids Res 34: D140-D144, 2006.
4. He L, Thomson JM, Hemann MT, et al: A microRNA polycistron as a potential human oncogene. Nature 435: 828-833, 2005. (Pubitemid 40839734)
5. Tam W and Dahlberg JE: miR-155/BIC as an oncogenic microRNA. Genes Chromosomes Cancer 45: 211-212, 2006. (Pubitemid 43191028)
6. Papagiannakopoulos T, Shapiro A and Kosik KS: MicroRNA-21 targets a network of key tumor-suppressive pathways in glioblastoma cells. Cancer Res 68: 8164-8172, 2008.
7. Hammond SM: MicroRNAs as tumor suppressors. Nat Genet 39: 582-583, 2007.
8. Tazawa H, Tsuchiya N, Izumiya M and Nakagama H: Tumor-suppressive miR-34a induces senescence-like growth arrest through modulation of the E2F pathway in human colon cancer cells. Proc Natl Acad Sci USA 104: 15472-15477, 2007. (Pubitemid 47502941)
9. Yanaihara N, Caplen N, Bowman E, et al: Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. Cancer Cell 9: 189-198, 2006. (Pubitemid 43357945)
10. Mattie MD, Benz CC, Bowers J, et al: Optimized high-throughput microRNA expression profiling provides novel biomarker assessment of clinical prostate and breast cancer biopsies. Mol Cancer 5: 24, 2006.
11. Chen Y and Stallings RL: Differential patterns of microRNA expression in neuroblastoma are correlated with prognosis, differentiation, and apoptosis. Cancer Res 67: 976-983, 2007.
12. Ru Y, Dancik GM and Theodorescu D: Biomarkers for prognosis and treatment selection in advanced bladder cancer patients. Curr Opin Urol 21: 420-427, 2011.
13. Eis PS, Tam W, Sun L, et al: Accumulation of miR-155 and BIC RNA in human B cell lymphomas. Proc Natl Acad Sci USA 102: 3627-3632, 2005. (Pubitemid 40354662)
14. Wald AI, Hoskins EE, Wells SI, Ferris RL and Khan SA: Alteration of microRNA profiles in squamous cell carcinoma of the head and neck cell lines by human papillomavirus. Head Neck 33: 504-512, 2011.
15. Kong W, He L, Coppola M, Guo J, Esposito NN, Coppola D and Cheng JQ: MicroRNA-155 regulates cell survival, growth, and chemosensitivity by targeting FOXO3a in breast cancer. J Biol Chem 285: 17869-17879, 2010.
16. Volinia S, Calin GA, Liu CG, et al: A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci USA 103: 2257-2261, 2006. (Pubitemid 43271657)
17. Juan D, Alexe G, Antes T, et al: Identification of a microRNA panel for clear-cell kidney cancer. Urology 75: 835-841, 2010.
18. Du ZM, Hu LF, Wang HY, Yan LX, Zeng YX, Shao JY and Ernberg I: Upregulation of MiR-155 in nasopharyngeal carcinoma is partly driven by LMP1 and LMP2A and downregulates a negative prognostic marker JMJD1A. PLoS One 6: e19137, 2011.
19. Bundred NJ: Prognostic and predictive factors in breast cancer. Cancer Treat Rev 27: 137-142, 2001.
20. Devi KR, Kuruvila S and Musa MM: Pathological prognostic factors in breast carcinoma. Saudi Med J 21: 372-375, 2000.
21. Wiseman SM, Makretsov N, Nielsen TO, et al: Coexpression of the type 1 growth factor receptor family members HER-1, HER-2, and HER-3 has a synergistic negative prognostic effect on breast carcinoma survival. Cancer 103: 1770-1777, 2005. (Pubitemid 40563247)
22. Singletary SE, Allred C, Ashley P, et al: Staging system for breast cancer: revisions for the 6th edition of the AJCC Cancer Staging Manual. Surg Clin North Am 83: 803-819, 2003. (Pubitemid 36841911)
23. Zhang RG, Zhang RP, Wang XW and Xie H: Effects of cisplatin on telomerase activity and telomere length in BEL-7404 human-hepatoma cells. Cell Res 12: 55-62, 2002. (Pubitemid 135708304)
24. O'Connell RM, Taganov KD and Boldin MP: MicroRNA-155 is induced during the macrophage inflammatory response. Proc Natl Acad Sci USA 104: 1604-1609, 2007. (Pubitemid 46214637)
25. O'Connell RM, Kahn D, Gibson WS, et al: MicroRNA-155 promotes autoimmune inflammation by enhancing inflammatory T cell development. Immunity 33: 607-619, 2010.
26. Bhattacharyya S, Balakathiresan NS, Dalgard C, et al: Elevated miR-155 promotes inflammation in cystic fibrosis by driving hyperexpression of interleukin-8. J Biol Chem 286: 11604-11615, 2011.
27. O'Connell RM, Rao DS, Chaudhuri AA, et al: Sustained expression of microRNA-155 in hematopoietic stem cells causes a myeloproliferative disorder. J Exp Med 205: 585-594, 2008. (Pubitemid 351439306)
28. Urbich C, Kuehbacher A and Dimmeler S: Role of microRNAs in vascular diseases, inflammation, and angiogenesis. Cardiovasc Res 79: 581-588, 2008.
29. Jiang S, Zhang HW, Lu MH, et al: MicroRNA-155 functions as an OncomiR in breast cancer by targeting the suppressor of cytokine signaling 1 gene. Cancer Res 70: 3119-3127, 2010.
30. Pedersen IM, Otero D, Kao E, Miletic AV, et al: Onco-miR-155 targets SHIP1 to promote TNFalpha-dependent growth of B cell lymphomas. EMBO Mol Med 1: 288-295, 2009.
31. Tili E, Croce CM and Michaille JJ: miR-155: on the crosstalk between inflammation and cancer. Int Rev Immunol 28: 264-284, 2009.
32. Iorio MV, Ferracin M, Liu CG, et al: MicroRNA gene expression deregulation in human breast cancer. Cancer Res 65: 7065-7070, 2005. (Pubitemid 41161233)
33. Wrba F, Reiner A, Markis-Ritzinger E, Holzner JH, Reiner G and Spona J: Prognostic significance of immunohistochemical parameters in breast carcinomas. Pathol Res Pract 183: 277-283, 1988.
34. Carter CL, Allen C and Henson DE: Relation of tumor size, lymph node status, and survival in 24,740 breast cancer cases. Cancer 63: 181-187, 1989. (Pubitemid 19032001)
35. De Azambuja E, Cardoso F, de Castro G Jr, et al: Ki-67 as prognostic marker in early breast cancer: a meta-analysis of published studies involving 12,155 patients. Br J Cancer 96: 1504-1513, 2007. (Pubitemid 46762956)
36. Zhu W, Qin W, Atasoy U and Sauter ER: Circulating microRNAs in breast cancer and healthy subjects. BMC Res Notes 2: 89, 2009.
37. Lu J and Tsourkas A: Imaging individual microRNAs in single mammalian cells in situ. Nucleic Acids Res 37: e100, 2009.
38. Lee YT and Markland FS: Steroid receptors study in breast carcinoma. Med Pediatr Oncol 5: 153-166, 1978. (Pubitemid 9169637)
39. Paone JF, Abeloff MD, Ettinger DS, Arnold EA and Baker RR: The correlation of estrogen and progesterone receptor levels with response to chemotherapy for advanced carcinoma of the breast. Surg Gynecol Obstet 152: 70-74, 1981. (Pubitemid 11210189)
40. Clark GM and McGuire WL: Prognostic factors in primary breast cancer. Breast Cancer Res Treat 3 (Suppl): S69-S72, 1983.
41. Linnstaedt SD, Gottwein E, Skalsky RL, Luftig MA and Cullen BR: Virally induced cellular microRNA miR-155 plays a key role in B-cell immortalization by Epstein-Barr virus. J Virol 84: 11670-11678, 2010.
42. Qin A, Zhou Y, Sheng M, Fei G, Ren T and Xu L: Effects of microRNA-155 on the growth of human lung cancer cell line 95D in vitro. Zhongguo Fei Ai Za Zhi 14: 575-580, 2011.